Chelsea Therapeutics (CHTP +1.6%) receives a notice of allowance from the U.S. Patent Office for...

|About: Chelsea Therapeutics Intern... (CHTP)|By:, SA News Editor

Chelsea Therapeutics (CHTP +1.6%) receives a notice of allowance from the U.S. Patent Office for its Northera Controlled Release Formulation patent application. The patent will establish protection for the drug's once-a-day treatment beyond the seven-year marketing exclusivity afforded by its orphan designation in the U.S..